Category Archives: Levaquin

Featured Stories

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

FDA Panel Says Safety Warnings Inadequate for Fluoroquinolones

In a safety announcement issued on May 12, 2016, the U.S. Food and Drug Administration (FDA) announced label changes for fluoroquinolone drugs to warn of serious side effects associated with these drugs. The FDA says these risks generally outweigh the … Continue reading

Posted in Defective Products, Health Concerns, Levaquin, Pharmaceuticals |

FDA Omits Serious Side Effects From Levaquin Label, Update Urged

FDA Omits Serious Side Effects From Levaquin Label

The Food and Drug Administration (FDA) is facing pressure to amend the warning label of Levaquin and other antibiotics in its class to include serious and sometimes fatal side effects of the fluoroquinolones. Cleveland television station ABC5 (WEWS) obtained a … Continue reading

Posted in Cipro, Defective Products, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , |

FDA Report Indicates Levaquin, Other Similar Antibiotics May be Linked to Mitochondrial Toxicity

Levaquin & Other Antibiotics Linked to Mitochondrial Toxicity

Levaquin, Cipro and other medications are part of a family of antibiotics known as fluoroquinolones, which are commonly used to treat infections. In 2013, the U.S. Food and Drug Administration (FDA) added a black box warning, the agency’s most serious … Continue reading

Posted in Health Concerns, Legal News, Levaquin, Toxic Substances | Tagged , , , , , |

New Lawsuit Filed Against Janssen Pharmaceuticals Over Levaquin Nerve Damage

Lawsuit Filed Against (Levaquin) Janssen Pharmaceuticals

Janssen Pharmaceuticals and drug distributor McKeeson Corp. were hit with a lawsuit last week in Pennsylvania federal court by a Texas woman who says the companies failed to warn of known dangers of the antibiotic Levaquin, which she alleges caused … Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , , |

FDA Failed to Warn Public of Serious Side Effect Linked to Antibiotic Levaquin

FDA Failed to Warn Public of Levaquin Side Effect

The Food and Drug Administration (FDA) failed to disclose a serious side effect associated with the family of antibiotics known as fluoroquinolones identified in a 2013 agency report. In an investigation, Cleveland television station ABC5 obtained a 2013 FDA report … Continue reading

Posted in Cipro, Defective Products, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , |

Antibiotics Linked with Increased Arrhythmias and Death Risk

A new study indicates that short-term treatment with the antibiotics azithromycin and levofloxacin may increase the risk of serious cardiac arrhythmias and death. Research has shown a relationship between azithromycin use and an increased risk of cardiovascular death and all-cause … Continue reading

Posted in Health Concerns, Levaquin, Pharmaceuticals, Zithromax |

Broad-spectrum Antibiotics Overused, Studies Say

overuse_antobiotics_wide_spectrum

Research from organizations including the American Academy of Pediatrics and the Centers for Disease Control and Prevention (CDC) urges doctors to limit the use of broad-spectrum antibiotics like Cipro (ciprofloxacin). Recent studies have shown that doctors are overprescribing broad-spectrum antibiotics, … Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals, Zithromax |

Common Antibiotics Linked to Eye Damage Risk

antibiotic_eye_damage

A year after a Canadian research study showed a connection between commonly prescribed antibiotics and blindness-inducing eye damage, patients and physicians still aren’t reporting these reactions to Health Canada. An article in the latest Canadian Adverse Reaction Newsletter suggests that … Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals |

FDA: Zithromax May Lead to Potentially Fatal Heart Rhythms

The U.S. Food & Drug Administration is warning the public that Zithromax (azithromycin), also known as Zmax can cause abnormal changes in the electrical activity of the heart. This may lead to a potentially fatal irregular heart rhythm. Patients at … Continue reading

Posted in Cipro, Levaquin, Pharmaceuticals, Zithromax |

Cipro, Levaquin, Avelox Linked to Dangerous Side Effects

Antibiotics such as Cipro, Levaquin, and Avelox have been linked to dangerous side effects. All three are in a class of antibiotic medications known as fluoroquinolones. According to The New York Times’ blog, Well, the strong antibiotic drugs in the … Continue reading

Posted in Levaquin, Pharmaceuticals | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.